关注
Simon Bissonnette
Simon Bissonnette
Clinicial biochemistry fellow, Université de Montréal
在 umontreal.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue
S Bissonnette, H Salem, H Wassef, N Saint-Pierre, A Tardif, A Baass, ...
Journal of lipid research 54 (5), 1466-1476, 2013
402013
Plasma IL-1Ra: linking hyperapoB to risk factors for type 2 diabetes independent of obesity in humans
S Bissonnette, N Saint-Pierre, V Lamantia, Y Cyr, H Wassef, M Faraj
Nutrition & Diabetes 5 (9), e180-e180, 2015
342015
The apoB-to-PCSK9 ratio: a new index for metabolic risk in humans
H Wassef, S Bissonnette, N Saint-Pierre, V Lamantia, Y Cyr, M Chrétien, ...
Journal of Clinical Lipidology 9 (5), 664-675, 2015
332015
White adipose tissue apolipoprotein CI secretion in relation to delayed plasma clearance of dietary fat in humans
H Wassef, H Salem, S Bissonnette, A Baass, R Dufour, J Davignon, ...
Arteriosclerosis, thrombosis, and vascular biology 32 (11), 2785-2793, 2012
282012
ApoB-lipoproteins and dysfunctional white adipose tissue: Relation to risk factors for type 2 diabetes in humans
V Lamantia, S Bissonnette, H Wassef, Y Cyr, A Baass, R Dufour, ...
Journal of Clinical Lipidology 11 (1), 34-45. e2, 2017
242017
High plasma apolipoprotein B identifies obese subjects who best ameliorate white adipose tissue dysfunction and glucose-induced hyperinsulinemia after a hypocaloric diet
S Bissonnette, N Saint-Pierre, V Lamantia, C Leroux, V Provost, Y Cyr, ...
The American journal of clinical nutrition 108 (1), 62-76, 2018
202018
Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface‐expression of LDLR and CD36 and NLRP3 inflammasome
Y Cyr, V Lamantia, S Bissonnette, M Burnette, A Besse‐Patin, A Demers, ...
Physiological Reports 9 (3), e14721, 2021
192021
White adipose tissue surface expression of LDLR and CD36 is associated with risk factors for type 2 diabetes in adults with obesity
Y Cyr, S Bissonnette, V Lamantia, H Wassef, E Loizon, ET Ngo Sock, ...
Obesity 28 (12), 2357-2367, 2020
182020
WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects [S]
Y Cyr, H Wassef, S Bissonnette, V Lamantia, J Davignon, M Faraj
Journal of Lipid Research 57 (6), 1074-1085, 2016
142016
The association of polyunsaturated fatty acid δ-5-desaturase activity with risk factors for type 2 diabetes is dependent on plasma ApoB-lipoproteins in overweight and obese adults
V Lamantia, S Bissonnette, V Provost, M Devaux, Y Cyr, C Daneault, ...
The Journal of Nutrition 149 (1), 57-67, 2019
132019
Increased fiber intake predicts the decrease in 2nd phase glucose-induced hyperinsulinemia following a hypocaloric diet in obese subjects
V Provost, V Lamantia, S Bissonnette, Y Cyr, M Faraj
Nutrition, Metabolism and Cardiovascular Diseases 29 (5), 504-512, 2019
62019
Enrichment of triglyceride-rich lipoproteins with apolipoprotein CI is positively associated with their delayed plasma clearance independently of other transferable …
H Wassef, S Bissonnette, R Dufour, J Davignon, M Faraj
The Journal of Nutrition 147 (5), 754-762, 2017
62017
Native low-density lipoproteins are priming signals of the NLRP3 inflammasome/interleukin-1β pathway in human adipose tissue and macrophages
S Bissonnette, V Lamantia, B Ouimet, Y Cyr, M Devaux, R Rabasa-Lhoret, ...
Scientific Reports 13 (1), 18848, 2023
32023
ApoB-lipoproteins and PCSK9 as modulators of human white adipose tissue function and NLRP3 inflammasome activity
Y Cyr, S Bissonnette, V Lamantia, A Besse-Patin, E Fouilloux-Meugnier, ...
International Symposium on Atherosclerosis (ISA), Toronto, CANADA, JUN 09-12 …, 2018
32018
Native LDL are priming signals of white adipose tissue NLRP3 inflammasome in overweight and obese subjects
S Bissonnette, V Lamantia, Y Cyr, V Provost, M Devaux, M Faraj
Atherosclerosis Supplements 32, 123, 2018
32018
Higher adipose tissue surface-expression of LDLR and CD36 and risk factors for T2D in normocholesterolemic subjects with low plasma PCSK9
Y Cyr, S Bissonnette, V Lamantia, V Provost, M Devaux, G Mayer, ...
Atherosclerosis Supplements 32, 70-71, 2018
22018
EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors
V Lamantia, S Bissonnette, M Beaudry, Y Cyr, CD Rosiers, A Baass, ...
Scientific Reports 14 (1), 27146, 2024
2024
Sex-Specific Models to Predict Insulin Secretion and Sensitivity in Subjects with Overweight and Obesity
M Beaudry, S Bissonnette, V Lamantia, M Devaux, M Faraj
International Journal of Molecular Sciences 24 (7), 6130, 2023
2023
77-OR: Native LDL Upregulate the NLRP3 Inflammasome in Human Adipose Tissue: A Mechanism for Higher Risk for Type 2 Diabetes in Subjects with HyperapoB
S Bissonnette, V Lamantia, Y Cyr, M Devaux, R Rabasa-Lhoret, ...
Diabetes 71 (Supplement_1), 2022
2022
Les apoB-lipoprotéines en tant que modulateurs de la fonction du tissu adipeux et des facteurs de risque du diabète de type 2 chez l'humain
S Bissonnette
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20